PRMT5 Inhibition Enhances Therapeutic Efficacy of Cisplatin via Mediating miR-29b-3p-Mcl-1 Expression in Lung Adenocarcinoma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Haichao,Li

第一单位： Department of Thoracic Surgery, The Second Affiliated Hospital, Air Force Medical University, Xi'an, Shaanxi Province, China.

作者： Haichao,Li ^[1] ; Jiangjiang,Fan ^[1] ; Weiwei,Shen ^[2] ; Yong,Zhang ^[3] ; Ximing,Zhu ^[1] ; Pei,Li ^[1] ; Zhongping,Gu ^[1] ; Pengyu,Jing ^[1]

作者单位： Department of Thoracic Surgery, The Second Affiliated Hospital, Air Force Medical University, Xi'an, Shaanxi Province, China. ^[1] Department of Oncology, The Second Affiliated Hospital, Air Force Medical University, Xi'an, Shaanxi Province, China. ^[2] Department of Pulmonary Medicine, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi Province, China. ^[3]

关键词 Mcl‐1 PRMT5 apoptosis cisplatin chemosensitivity lung adenocarcinoma

DOI 10.1002/cbin.12278

PMID 39891587

发布时间 2025-02-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cell biology international

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

PRMT5 Inhibition Enhances Therapeutic Efficacy of Cisplatin via Mediating miR-29b-3p-Mcl-1 Expression in Lung Adenocarcinoma.

Cell biology international

相似文献

Cell biology international

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

PRMT5 Inhibition Enhances Therapeutic Efficacy of Cisplatin via Mediating miR-29b-3p-Mcl-1 Expression in Lung Adenocarcinoma.

Cell biology international

相似文献

Cell biology international

相关期刊

检索历史清除